Clinical Trial Update: Phase II Study of DCVAC/PCa After Primary Radiotherapy for Patients With High Risk Localized Prostate Cancer [Phase 2]

View source ↗

Summary

Phase II trial update for DCVAC/PCa following primary radiotherapy in high-risk localized prostate cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• DCVAC/PCa (dendritic cell vaccine DCVAC/PCa)

Snippet

Sponsor: SOTIO a.s. | Conditions: Prostate Cancer | Phase 2 | Status: COMPLETED